Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis

Evaluation of presepsin as a diagnostic tool in newborns with risk of early-onset neonatal sepsis

ObjectivesTo evaluate the efficacy of presepsin (P-SEP) as a potential biomarker of early-onset neonatal sepsis (EOS) and compare it to other routinely used markers of inflammation. To establish the cut-off values of P-SEP for EOS.Study design184 newborns were prospectively recruited between January...

Full description

Bibliographic Details
Main Authors: Iva Pospisilova, Helena L. Brodska, Marketa Bloomfield, Klara Borecka, Jan Janota
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Pediatrics
Subjects:
biomarker
inflammation
neonatal sepsis
newborns
presepsin
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.1019825/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.1019825/full

Similar Items